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Abstract
Introduction The objective of the present study was to compare the health-related quality of life
(HR-QoL) of survivors from severe sepsis and septic shock with HR-QoL in others who survived
critical illness not involving sepsis.
Methods From March 1997 to March 2001, adult patients in an eight-bed medical/surgical intensive
care unit (ICU) of a tertiary care hospital admitted with severe sepsis or septic shock (sepsis group;
n = 305) were enrolled and compared with patients admitted without sepsis (control group; n = 392).
Patients younger than 18 years (n = 48) and those whose ICU stay was 1 day or less (n = 453) were
excluded. In addition, patients exhibiting nonsevere sepsis on admission were excluded (n = 87).
Finally, patients who developed nonsevere sepsis or severe sepsis/septic shock after admission were
also excluded (n = 88).
Results In-hospital mortality rates were 34% in the sepsis group and 26% in the control group. There
were no differences in sex, age, main activity (work status), and previous health state between groups.
Survivors in the sepsis group had a significantly higher Acute Physiology and Chronic Health
Evaluation II score on admission (17 versus 12) and stayed significantly longer in the ICU. A follow-up
appointment was held 6 months after ICU discharge, and an EQ-5D (EuroQol five-dimension)
questionnaire was administered. A total of 104 sepsis survivors and 133 survivors in the control group
answered the EQ-5D questionnaire. Sepsis survivors reported significantly fewer problems only in the
anxiety/depression dimension. Although there were no significant differences in the other dimensions
of the EQ-5D, there was a trend towards fewer problems being reported by sepsis survivors.
Conclusion Evaluation using the EQ-5D at 6 months after ICU discharge indicated that survivors from
severe sepsis and septic shock have a similar HR-QoL to that of survivors from critical illness admitted
without sepsis.
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Introduction
Sepsis has been identified as the leading cause of death in
critically ill patients in several epidemiological studies [1–3].
Angus and coworkers [1] estimated the incidence of sepsis
in the USA at 3.0 cases per 1000 population. Mortality is
high, ranging from 28% to 80%, and depend on several
factors including severity of the sepsis, number of acute
organ failures, age and comorbidities [1–5]. Sepsis is also
associated with prolonged stay both in intensive care unit
(ICU) and in hospital [1–5].
During the first year after an episode of sepsis mortality rates
remain high, and the sepsis-associated risk for dying may
persist up to 5 years after hospitalization [2]. This suggests
that increased mortality persists for a number of years after an
episode of sepsis, despite the acute nature of the disease
process [6].
Considerable resources have been invested in developing
and evaluating potential therapies for sepsis [1]. The most
recent example of this is the Surviving Sepsis Campaign, a
collaborative project from three major intensive care
organizations: the European Society of Intensive Care Medicine,
the Society of Critical Care Medicine and the International
Sepsis Forum. In 2002, a reduction in the relative mortality
from sepsis by 25% over the next 5 years was declared as
the main objective of the Campaign [7,8].
Sepsis survivors often present with residual organ dysfunction,
which may result in persistent symptoms such as dyspnoea,
fatigue [9–12], depression, impaired functional status and
reduced health-related quality of life (HR-QoL) in comparison
with the general population [13–15]. Recognition of these
long-term sequelae in survivors from critical illnesses has
shifted outcome values from reduction in hospital mortality to
‘patient centered outcomes’ [16], such as HR-QoL. In this
regard, studies such as that recently conducted by Herridge
and coworkers [17] in survivors from acute respiratory distress
syndrome (which may largely be caused by sepsis) have
suggested that these sequelae may represent the typical
residua of any severe critical illness, rather than being specific
to the syndrome. This draws our attention to the impact of age
and premorbid conditions on subsequent HR-QoL.
Although we have not yet achieved consensus on the optimal
way to evaluate HR-QoL, it was recently recommended that
the EQ-5D (EuroQol five-dimension) questionnaire, a generic
instrument, be used in the critical care setting [18]. The aim
of the present study was to compare HR-QoL, using the EQ-
5D [19,20], in survivors from severe sepsis and septic shock
with HR-QoL in survivors from critical illness admitted without
sepsis, 6 months after ICU discharge.
Methods
Patients
From March 1997 to March 2001, all adult patients in an
eight-bed medical/surgical ICU of a tertiary care hospital who
were admitted with severe sepsis or septic shock (sepsis
group) were enrolled and compared with patients admitted
without sepsis (control group). Patients in the sepsis group
were those in whom severe sepsis and septic shock was the
reason for admission to the ICU, according to the criteria
defined by the 2001 International Sepsis Definitions
Conference [21]: patients with severe sepsis were those
admitted with sepsis complicated by organ dysfunction; and
patients with septic shock were those with sepsis and
persistent arterial hypotension (systolic arterial pressure
<90 mmHg) despite adequate volume resuscitation.
Patients younger than 18 years old were excluded, as were
those whose duration of stay in the ICU was 1 day or less,
because most of them were admitted only for postoperative
surveillance. Patients exhibiting nonsevere sepsis on admission
were also excluded. Moreover, patients who developed
nonsevere sepsis or severe sepsis/septic shock after
admission were excluded from the control group (Fig. 1).
From a total of 1285 patients, 501 were excluded (48 for
being younger than 18 years and 453 for having a duration of
stay in the ICU of 1 day or less). Patients readmitted during
the study period were enrolled in relation to their time of first
admission. A total of 87 patients were excluded because they
had nonsevere sepsis on admission.
From the 697 patients included in the study, 305 were
admitted for severe sepsis or septic shock (sepsis group)
and 392 were admitted without sepsis (control group). Of the
latter patients, 87 were subsequently excluded because they
developed either nonsevere sepsis or severe sepsis/septic
shock after admission (Fig. 1).
Patients in the sepsis group had a higher mortality, although
this was not statistically significant; mortality rates in the ICU
and in the ward were 25% and 12% (34% in-hospital
mortality) in the sepsis group, respectively, and 19% and 8%
in the control group, respectively (26% in-hospital mortality).
Mortality rates during the following 6 months after discharge
were 9% in the sepsis group and 8% in the control group.
At 6 months after ICU discharge, 80 survivors from the sepsis
group did not come to the follow-up consultation, 50 for
unknown reasons (nonrespondents; 27%) and 30 for known
reasons, namely living in distant locations (n = 26), being in
prison (n = 3), or being bedridden (n = 1). One hundred and
four (34%) survivors from the sepsis group came to the
follow-up consultation and completed the EQ-5D
questionnaire. In the control group, 74 survivors did not come
to the follow-up consultation, 44 because of unknown
reasons (nonrespondents; 21%) and 30 for known reasons,R93
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Figure 1
Patients admitted and excluded from the study. Mortality, survival, and rate of EuroQol five-dimension (EQ-5D) response in the sepsis group and in
the control group are shown.R94
namely living in distant locations (n = 27), being in prison
(n = 1) and being bedridden (n = 2). One hundred and thirty-
three (44%) survivors completed the EQ-5D questionnaire
(Fig. 1). The difference in response rate between the groups
(34% versus 44%) was statistically significant (P = 0.015).
Patients in the control group presented with several different
admission diagnoses, with the most frequent being post-
operative respiratory failure, postoperative surveillance, multiple
trauma, craniotomy for neoplasm, post-cardiac arrest, congestive
heart failure, and cerebral hemorrhage (Table 1).
Measures
Background, ICU, and EQ-5D variables were compared
between the groups. Background variables included patient’s
sex, age, work status, and previous health status. Previous
health state was evaluated according to three categories:
healthy, chronic nondisabling diseases (i.e. able to keep work
or normal daily activities), and chronic disabling diseases (i.e.
unable to work or to undertake normal daily activities). One of
the authors classified all patients according to one of these
three categories. This classification was based on previous
clinical history obtained from clinical registrations, from direct
information from the patient, or from information from the
patient’s proxies. ICU variables included severity of disease at
admission, as measured using the Acute Physiology and
Chronic Health Evaluation (APACHE) II scale, duration of ICU
stay, and admission category.
HR-QoL was measured using EQ-5D questionnaire. This is a
generic instrument designed to measure health outcomes,
developed at the European level [19,20]. The EuroQol Group
originally developed the Portuguese version of the EQ-5D in
1998 (www.euroqol.org). The EQ-5D comprises two parts:
the EQ-5D self-classifier, a self-reported description of health
problems according to a five dimensional classification i.e.,
mobility, self-care, usual activities, pain/discomfort and anxiety/
depression (see Table 4 for description of the EQ-5D self-
classifier); the EQ VAS, a self-rated health status using a
visual analogue scale (VAS), similar to a thermometer, to
record perceptions of participants own current overall health;
the scale is graduated from 0 (the worst imaginable health
state) to 100 (the best imaginable state) [19,20]. In both, the
timeframe is the current day. Because the ICU stay was only
6 months before the interview, the ‘perceived current health
status’ originally asked about in the EQ-5D questionnaire was
changed from ‘Compared with my general level of health over
the past 12 months my health state today is better/the
same/worse’ to ‘Compared with my general level of health
12 months ago my health state today is better/the same/
worse’. An index (EQ Index), based on the five dimensions and
the EQ VAS and ranging from 0 to 100, was also calculated
and used to describe the overall QoL of the patients [22].
All questionnaires were administered by one of the authors
during a follow-up consultation at 6 months after ICU discharge.
Informed consent was obtained from all patients at the time of
the follow-up consultation, and the hospital’s ethics
committee approved the study.
Statistical analysis
Pearson χ2 tests were used to analyze categorical data, and
Mann–Whitney tests were used for continuous variables with
asymmetric distribution. P < 0.05 was considered to be
statistically significant.
Results
There were significant differences between sepsis survivors
and nonsurvivors with respect to background variables; those
who died were significantly older than those who survived.
Concerning ICU variables, we found significant differences in
severity of disease, in that those who died had more severe
disease, as measured using the APACHE II scale. There were
no significant differences between survivors and non-survivors
with respect to origin of sepsis. Also, the source of infection
was respiratory in 62% of the patients who survived (Table 2).
There were no significant differences in background and ICU
variables between respondents and nonrespondents in the
sepsis group and in the control group (Table 3). Regarding
background and ICU variables, there were no significant
differences between respondents in the sepsis group and
patients excluded from the control group, except in admission
category, because there were no scheduled surgery patients
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Table 1
Diagnosis of respondents from the control group
Diagnosis n (%)
Postoperative respiratory failure 24 (18)
Postoperative surveillance 16 (12)
Multiple trauma 10 (7)
Craniotomy for neoplasm 9 (7)
Post-cardiac arrest 8 (6)
Congestive heart failure 8 (6)
Cerebral hemorrage 8 (6)
Hemorrhagic shock 7 (5)
Intoxication 5 (4)
Acute pancreatitis 5 (4)
Gastrointestinal surgery for neoplasm 5 (4)
Seizures 4 (3)
Others 22 (17)
Not registered 1 (1)
Total 133 (100)
The control group comprised patients admitted to the intensive care
unit but without sepsis or septic shock.R95
in the sepsis group. There were significant differences in
admission category and in ICU duration of stay between
patients excluded from the control group, and respondents
and nonrespondents from the sepsis group (Table 3).
There were no differences in sex, age, work status, and
previous health state between respondents from the sepsis
group and respondents from the control group (Table 4).
Respondents from the sepsis group had a significantly higher
APACHE II score (17 versus 12) and stayed significantly
longer in the ICU than did respondents from the control
group. There were no admissions after scheduled surgery in
the sepsis group, which is as expected because patients with
sepsis would not undergo scheduled surgery.
Usual activities and anxiety/depression were the dimensions
in which respondents reported more problems, both in the
sepsis and in the control group. Sepsis respondents
reported no problems in the five dimensions of the EQ-5D
at percentages ranging from 54% for usual activities to
76% for self-care. These percentage was lower in the
control group, and ranged from 39% for anxiety/depression
to 73% for self-care. Significant differences in HR-QoL
were found only for the anxiety/depression dimension, in
which sepsis respondents reported significantly fewer
problems (Table 4). Concerning all the other dimensions of
the EQ-5D, there was a trend toward sepsis respondents
reporting fewer problems than respondents from the control
group, although this did not reach statistical significance.
This trend was evident in perceived current health state, in
which there was a significant difference between groups;
67% in the sepsis group and 58% in the control group
claimed to be better or the same than 12 months earlier.
There were no differences in EQ-VAS and EQ Index
between respondents from the groups.
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Table 2
Origin of sepsis in all patients from the sepsis group
Nonsurvivors Survivors 
Origin of sepsis Total (n)( n [%]) (n [%]) P
Respiratory 188 71 (38) 117 (62) 0.190a
Abdominal 83 41 (49) 42 (51)
Urinary 11 3 (27) 8 (73)
Otherb 23 6 (26) 17 (74)
The total number of survivors was 184 and the total number of non-
survivors was 121. aPearson χ2 test. bThis category includes
cardiovascular, systemic, central nervous systems, skin and soft tissue,
and indeterminate sites of sepsis origin in order to meet the χ2 test
criteria.
Table 3
Characteristics of survivors from the control group and the sepsis group
Control group Sepsis group
Total Subtotal R NR Excluded  Subtotal R NR
Characteristic (n = 479) (n = 295) (n = 133) (n = 74) (n = 88) Pa (n = 184) (n = 104) (n = 80) Pa Pb Pc
Sex (%)
Male 60 58 54 51 68
0.700d
64 64 63
0.809d 0.493d 0.407d
Female 40 42 46 49 32 36 36 37
Age (years; median  59 61 58 64 61 0.229e 57 52 62 0.139e 0.181e 0.486e
[25th–75th percentile]) (39–69) (40–70) (42–69) (39–75) (37–70) (38–68) (38–66) (39–69)
APACHE II score  16  14  12  14  18  0.740e 18 17  18  0.200e 0.591e 0.958e
(median [25th–75th  (11–21) (10–19) (8–18) (10–17) (13–22) (13–22) (13–21) (14–23)
percentile])
ICU days (median  5  4  3  3  9  0.695d 7 8  6  0.273d 0.052e 0.007e
[25th–75th percentile]) (3–10) (2–9) (2–5) (2–4) (5–15) (4–11) (4–11) (4–10)
Admission category (%)
Medical 54 38 31 31 55 79 77 81
Nonscheduled surgery 17 15 15 15 15
0.442d
20 22 18
0.711d <0.001d <0.001d
Scheduled surgery 20 34 44 37 15 0 0 0
Multiple Trauma 9 13 10 17 15 1 1 1
aComparisons between nonrespondents and respondents. bComparisons between nonsepsis excluded and severe sepsis respondents.
cComparisons between nonsepsis excluded and severe sepsis. dPearson χ2 test. eMann–Whitney test. APACHE, Acute Physiology and Chronic
Health Evaluation; R, respondents; NR, nonrespondentsR96
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Table 4
Background, intensive care unit, and EQ-5D variables in sepsis group and control group respondents
Sepsis group  Control group 
respondents respondents 
Type of data (n = 104) (n = 133) P
Background Sex (n [%])
Male 66 (64) 72 (54) 0.149a
Female  38 (36) 61 (46)
Age (median [25th–75th percentile]) 52 (38–66) 58 (42–69) 0.102b
Work status (n [%])
Employed  27 (27) 30 (23) 0.556a
Retired 53 (53) 65 (49)
Housework/student/seeking work  9 (9) 17 (13)
Other  11 (11) 20 (15)
Previous health state (n [%])
Healthy 33 (32) 36 (27) 0.518a
Chronic nondisabling disease 45 (44) 68 (51)
Chronic disabling disease 25 (24) 29 (22)
ICU variables APACHE II score at admission (median [25th–75th percentile])c 17 (13–21) 12 (8–18) <0.001
ICU days (median [25th–75th percentile])c 8 (4–11) 3 (2–5) <0.001b
Admission category (n [%])c
Medical  80 (77) 41 (31) <0.001a
Scheduled surgery 0 (0) 58 (44)
Nonscheduled surgery  23 (22) 20 (15)
Multiple trauma  1 (1) 13 (10)
EQ-5D variables Mobility (n [%])
N: I have no problems in walking about  69 (67) 77 (58) 0.368a
M: I have some problems in walking about  30 (29) 50 (38)
E: I am confined to bed  4 (4) 5 (4)
Self-care (n [%])
N: I have no problems with self-care  79 (76) 96 (73) 0.782a
M: I have some problems washing or dressing myself  11 (11) 16 (12)
E: I am unable to wash or dress myself  13 (13) 20 (15)
Usual activities (n [%])
N: I have no problems with performing my usual activities  56 (54) 58 (44) 0.192a
M: I have some problems with performing my usual activities  26 (25) 47 (36)
E: I am unable to performing my usual activities  21 (21) 27 (20)
Pain/discomfort (n [%])
N: I have no pain or discomfort  66 (64) 73 (55) 0.386a
M: I have moderate pain or discomfort  30 (29) 49 (37)
E: I have extreme pain or discomfort  7 (7) 10 (8)
Anxiety/depression (n [%])
N: I am not anxious or depressed  58 (56) 51 (39) 0.017a
M: I am moderately anxious or depressed  29 (28) 59 (46)
E: I am extremely anxious or depressed  16 (16) 19 (15)
Perceived current health state: Health state today compared with 12 months ago (n [%])c
Better  35 (34) 52 (40) 0.022a
The same 34 (33) 23 (18)
Worse  33 (33) 55 (42)
EQ VAS (median [25th–75th percentile]) 75 (50-80) 60 (50-80) 0.129b
EQ Index (median [25th–75th percentile]) 84 (58-100) 76 (56-91) 0.059b
aPearson χ2 test. bMann–Whitney test. *See Methods section for an explanation. APACHE, Acute Physiology and Chronic Health Evaluation; EQ-
5D, EuroQol five-dimension questionnaire; ICU, intensive care unit; VAS, visual–analogue scale (0–100% scale).R97
Discussion
In the present study we found that sepsis survivors had a
significantly higher APACHE II score on admission and had a
significantly longer median duration of stay in the ICU than
did the control group. Sepsis mortality was significantly
associated with age and severity of disease. Sepsis survivors
exhibited a fair HR-QoL, whereas moderate to extreme
problems were reported at a percentage ranging from 24%
to 46% in the five dimensions of the EQ-5D. Respondents
from both groups reported more problems with the dimensions
usual activities and anxiety/depression. There were no
significant differences in HR-QoL between the sepsis group
and the control group, except for anxiety/depression, for which
sepsis respondents reported significantly fewer problems.
Sepsis survivors had a significantly higher APACHE II score
on admission and had a significantly longer median duration
of ICU stay, a finding that has been described in most studies
including sepsis patients [1–5]. Sepsis mortality was
significantly associated with age and severity of disease,
which is in accordance with previous reports [1–3,5]. Several
studies have reported lower mortality in urinary sepsis and
higher mortality in abdominal sepsis [5,21], which was also
found in the present study but without reaching statistical
significance. In-hospital mortality was 34%; although this is in
agreement with some previous reports [1,2], it is less than in
other ones [3,5].
We found a fair HR-QoL overall among sepsis survivors, but
moderate to severe problems were reported by a percentage
ranging from 24% to 46% in the five dimensions of the
EQ-5D. This agrees with previous reports, in which a fair HR-
QoL was found in survivors from sepsis [13], although such
patients may exhibit reductions in HR-QoL as compared with
the general population [14,15]. Except for anxiety/
depression, we did not find differences in HR-QoL between
respondents admitted with severe sepsis or septic shock and
those admitted without sepsis. Sepsis respondents in the
present study performed significantly better on anxiety/
depression dimension compared with the control group, and
this is in accord with findings reported by Heyland and
coworkers [14] and Perl and colleagues [15] that sepsis
survivors exhibit no differences in the emotional component
when compared with the general population.
Although having a greater severity of disease on admission,
sepsis respondents performed as well as or even better than
other ICU survivors when evaluated 6 months after ICU
discharge. This finding emphasizes the reversibility of sepsis,
whereas other critically ill patients, such as those included in the
control group, may suffer more permanent sequelae related
either to the disease responsible for ICU admission or to
previous health status. It again raises the question of whether
reductions in HR-QoL found in survivors from specific
diagnostic groups of critical illness are indistinguishable from
those in other critically ill patients [23,24]. Hence, such
reductions may be cohort specific [17] and may be
predominantly due to a higher burden of comorbid disease [25].
To our knowledge, this is the first study using the EQ-5D
questionnaire in a cohort of sepsis survivors. It was recently
recommended that this instrument be used in critical care
outcome studies, along with SF-36, on the grounds that it is
perhaps among the instruments that are best suited to this
setting [18]. We have applied the EQ-5D in several groups of
ICU survivors [23,24,26] and have demonstrated that it is a
suitable generic instrument for use in critical care patients, as
have Badia and coworkers previously [27]. These studies
have helped us to improve our understanding of patients’ lives
after intensive care treatment, and this knowledge should drive
us to look for ways to prevent and improve post-critical illness
sequelae.
This study has some limitations. First, because we did not
make the distinction between severe sepsis and septic
shock, we were not able to associate mortality and HR-QoL
with severity of sepsis. Second, the significantly lower
response rate (P = 0.015) for the sepsis group could have
introduced a response bias, whereby survivors from the
sepsis group with a lower HR-QoL may be under-
represented. However, if the response rate is calculated in
relation to the rate of hospital discharge (P = 0.113) or even
to the rate of survival 6 months after ICU discharge
(P = 0.118), this difference becomes insignificant.
Conclusion
In conclusion, sepsis survivors have a fair HR-QoL at
6 months after ICU discharge, which is similar to the HR-QoL
of other critically ill survivors admitted without sepsis. This
should encourage early and aggressive treatment of sepsis in
order to improve survival and reduce morbidity – goals that
have been targeted by the Surviving Sepsis Campaign [7,8].
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Key messages
• HR-QoL in sepsis survivors 6 months after ICU 
discharge is fair and is no worse than the HR-QoL of
other critically ill patients admitted without sepsis
• The EQ-5D questionnaire is well suited for use in the
setting of critical care outcome studiesR98
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